Enhancement of antiproliferative activity by molecular simplification of catalpol

Bioorganic and Medicinal Chemistry

Volumn 18, Issue 7, 2010, Pages 2515-2523

  García, Celina ^a   León, Leticia G ^a,b   Pungitore, Carlos R ^c   Ríos Luci, Carla ^a   Daranas, Antonio H ^a   Montero, Juan C ^d   Pandiella, Atanasio ^d   Tonn, Carlos E ^c   Martín, Víctor S ^a   Padrón, José M ^a,b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b Madrid Spain   (Spain)

^c UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^d UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Antitumor agents; Catalpol; Cell cycle; Molecular simplification; Structure elucidation

Indexed keywords

CATALPOL; CYCLIN D1; IRIDOID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CONTROLLED STUDY; HUMAN; HUMAN CELL; SOLID TUMOR;

ANNEXIN A5; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME INHIBITORS; GLUCOSIDES; HUMANS; IRIDOIDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77950028535     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2010.02.044     Document Type: Article

References (23)

1. Tan G., Gyllenhaal C., and Soejarto D.D. Curr. Drug Targets 7 (2006) 265
2. Pezzuto J.M. Biochem. Pharmacol. 53 (1997) 121
3. Liu Z.-Z., Wang Y., Tang Y.-F., Chen S.-Z., Chen X.-G., and Li H.-Y. Bioorg. Med. Chem. Lett. 16 (2006) 1282
4. Altmann K.H. Curr. Pharm. Des. 11 (2005) 1595
5. Pinacho Crisóstomo F.R., Padrón J.M., Martín T., Villar J., and Martín V.S. Eur. J. Org. Chem. (2006) 1910
6. Córdova I., León L.G., León F., San Andrés L., Luis J.G., and Padrón J.M. Eur. J. Med. Chem. 41 (2006) 1327
7. Pungitore C.R., León L.G., García C., Martín V.S., Tonn C.E., and Padrón J.M. Bioorg. Med. Chem. Lett. 11 (2007) 1332
8. Pungitore C.R., Ayub M.J., Borkowski E.J., Tonn C.E., and Ciuffo G.M. Cell. Mol. Biol. 50 (2004) 767
9. Pungitore C.R., Ayub M.J., García M., Borkowski E.J., Sosa M.E., Ciuffo G., Giordano O.S., and Tonn C.E. J. Nat. Prod. 67 (2004) 357
10. Pratt W.B., Ruddon R.W., and Ensminger W.D. The Anticancer Drugs (1994), Oxford University Press, Oxford, UK
11. Mangion I.K., and MacMillan D.W.C. J. Am. Chem. Soc. 127 (2005) 3696
12. Brown S.P., Brochu M.P., Sinz C.J., and MacMillan D.W.C. J. Am. Chem. Soc. 125 (2003) 10808
13. Zhong G. Angew. Chem., Int. Ed. 42 (2003) 4247
14. Hayashi Y., Yamaguchi J., Hibino K., and Shoji M. Tetrahedron Lett. 44 (2003) 8293
15. Allinger N.L. J. Am. Chem. Soc. 99 (1977) 8127
16. Mohamadi F., Richards N.G.J., Guida W.C., Liskamp R., Lipton M., Caufield C., Chang G., Hendrickson T., and Still W.C. J. Comput. Chem. 11 (1990) 440
17. Still W.C., Tempczyk A., Hawley R.C., and Hendrickson T. J. Am. Chem. Soc. 112 (1990) 6127
18. Haasnoot C.A.G., De Leeuw F.A.A.M., and Altona C. Tetrahedron 36 (1980) 2783
19. Miranda P.O., Padrón J.M., Padrón J.I., Villar J., and Martín V.S. ChemMedChem 1 (2006) 323
20. Monks A., Scudiero D.A., Skehan P., Shoemaker R.H., Paull K.D., Vistica D.T., Hose C., Langley J., Cronice P., Vaigro-Wolf M., Gray-Goodrich M., Campbell H., and Mayo M.R. J. Natl. Cancer Inst. 83 (1991) 757
21. Mizushina Y., Xu X., Murakami C., Okano T., Takemura M., Yoshida H., and Sakaguchi K.J. J. Pharmacol. Sci. 92 (2003) 283
22. Alao J.P. Mol. Cancer 6 (2007) 24
23. Armarego W.L.F., and Perrin D.D. Purification of Laboratory Chemicals. fourth ed. (1996), Butterworth-Heinemann, Oxford